Organon (OGN) Restructuring Costs (2020 - 2026)
Organon (OGN) recorded quarterly Restructuring Costs of $31.0 million in Q1 2026, up 342.86% quarter-over-quarter from $7.0 million in Q4 2025, and down 63.95% on a YoY basis from $86.0 million in Q1 2025.
Organon (OGN) Restructuring Costs (2020 - 2026) Analysis & Trends
Organon's Restructuring Costs history runs 7 years deep, the most recent figure standing at $31.0 million for Q1 2026.
- In Q1 2026, Restructuring Costs fell 63.95% year-over-year to $31.0 million; the TTM figure through Mar 2026 stood at $40.0 million (down 57.45% YoY), while the FY2025 annual figure was $95.0 million, up 206.45% from the prior year.
- Restructuring Costs was $31.0 million for Q1 2026 at Organon, up from $7.0 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $86.0 million in Q1 2025 to a low of $2.0 million in Q2 2025.
- Historically, Restructuring Costs has averaged $24.9 million across 5 years, with a median of $14.0 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Restructuring Costs jumped 1000.0% in 2022, then sank 86.67% in 2024.
- A 5-year view of Restructuring Costs shows it stood at $17.0 million in 2022, then jumped by 252.94% to $60.0 million in 2023, then tumbled by 86.67% to $8.0 million in 2024, then decreased by 12.5% to $7.0 million in 2025, then jumped by 342.86% to $31.0 million in 2026.
- The last three Restructuring Costs figures came in at $31.0 million (Q1 2026), $7.0 million (Q4 2025), and $2.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,134,969.93 Bn | 92,134,964.97 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,027.45 Bn | 1,022.17 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 559.08 Bn | 537.03 Bn | 15.96 Bn |
| 4 | AbbVie | 394.75 Bn | 385.40 Bn | 10.78 Bn |
| 5 | Merck | 295.12 Bn | 289.47 Bn | 12.09 Bn |
| 6 | Amgen | 186.65 Bn | 174.61 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 159.22 Bn | 151.50 Bn | 5.52 Bn |
| 8 | Pfizer | 146.00 Bn | 133.23 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 113.22 Bn | 102.77 Bn | 8.07 Bn |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 86.00 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Mar 31, 2024 | 23.00 Mn |
| Dec 31, 2023 | 60.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | 11.00 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 17.00 Mn |
| Sep 30, 2020 | 12.00 Mn |
| Jun 30, 2020 | 19.00 Mn |
| Mar 31, 2020 | 12.00 Mn |